Cue Biopharma (CUE) Non-Current Assets (2017 - 2026)
Cue Biopharma's Non-Current Assets was $4.08 million in Q2 2026, down 58.6% from $9.86 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Cue Biopharma came in at $5.23 million, down 25.9% from FY2024.
- Non-Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -15.3% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $7.05 million in FY2024 (-30.0%), $10.08 million in FY2023 (-28.5%), $14.1 million in FY2022 (-5.6%) and $14.93 million in FY2021 (+24.4%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q3 2018.
- Compared with a year earlier, Non-Current Assets was higher in 1 of the last seven quarters, with an average decline of 26.5%.
- The best year-over-year quarter for Non-Current Assets over five years was Q3 2022 (growth of 69.4%); the worst was Q2 2026 (a decline of 58.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Cue Biopharma | 121.14 Mn | 30.41 Mn | - | 4.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Mn |
| Dec 31, 2025 | 5.23 Mn |
| Sep 30, 2025 | 5.83 Mn |
| Jun 30, 2025 | 9.86 Mn |
| Mar 31, 2025 | 6.32 Mn |
| Dec 31, 2024 | 7.05 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Jun 30, 2024 | 8.43 Mn |
| Mar 31, 2024 | 9.28 Mn |
| Dec 31, 2023 | 10.08 Mn |
| Sep 30, 2023 | 11.37 Mn |
| Jun 30, 2023 | 12.23 Mn |
| Mar 31, 2023 | 12.93 Mn |
| Dec 31, 2022 | 14.10 Mn |
| Sep 30, 2022 | 14.60 Mn |
| Jun 30, 2022 | 15.75 Mn |
| Mar 31, 2022 | 14.76 Mn |
| Dec 31, 2021 | 14.93 Mn |
| Sep 30, 2021 | 8.62 Mn |
| Jun 30, 2021 | 10.00 Mn |
API Access
Cue Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();